Skip to content

What is the 2025 treatment landscape of follicular lymphoma?
Facing 2026 with a mix of inspiration and trepidation
Adam Mead, MD, on interim phase 1 PROMise trial results in myelofibrosis
Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers
Pearl van Heteren, MD, on the DALY 2-EU trial in R/R DLBCL

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Cellular Therapy

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Leukemia

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Lymphoma

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Multiple Myeloma

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Myelodysplastic Syndromes

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

January 4, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Myelodysplastic Syndromes

MDS News

Photo of Dr. Garcia-Manero

ASH 2025 Myelodysplastic Syndromes

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

by SOHO Insider Editors
December 30, 2025
0 Comments

Leukemia Chronic Myeloid Leukemia Myelodysplastic Syndromes News

Pathways & Perspectives with Valeria Santini, MD

by Leah Sherwood
November 25, 2025
0 Comments

FDA editorial

Myelodysplastic Syndromes News

FDA grants orphan drug designation to MDS investigational therapy ofirnoflast

by SOHO Insider Editors
October 23, 2025
0 Comments

Digital tools

ESMO 2025 Acute Lymphoblastic Leukemia Aggressive B-Cell Lymphomas Multiple Myeloma Myelodysplastic Syndromes

Despite digital advances, cancer research remains costly, burdensome

by Leah Sherwood
October 22, 2025
0 Comments

Update

ESMO 2025 Myelodysplastic Syndromes News

Bexmarilimab continues to show strong efficacy in phase 1/2 trial update

by Leah Sherwood
October 21, 2025
0 Comments

Presenter speaking

Ambassador Program Myelodysplastic Syndromes Society Updates

SOHO MENA returns to in-person meeting for region’s 3rd meeting

by SOHO Insider Editors
October 20, 2025
0 Comments

Uma Borate presentation

SOHO 2025 Educational Resources Leukemia Meetings / Conferences Myelodysplastic Syndromes News

Improving Outcomes in CHIP/CCUS with Dr. Borate

by SOHO Insider Editors
October 20, 2025
0 Comments

FDA stamp on white paper

Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Myelodysplastic Syndromes News

FDA accepts BLA for Orca-T in hematological malignancies

by SOHO Insider Editors
October 15, 2025
0 Comments

Time for Phase 2. Hand holds a cube with number '2'. Word 'Phase 2'. Beautiful black background. Business concept. Copy space.

Acute Myeloid Leukemia Myelodysplastic Syndromes

Oral decitabine and cedazuridine combo shows promise as post-HSCT option

by Leah Sherwood
August 21, 2025
0 Comments

a globe

Acute Myeloid Leukemia Myelodysplastic Syndromes

Treatment post-relapse improves survival outcomes in patients with AML or MDS

by SOHO Insider Editors
August 11, 2025
0 Comments

1
2
3

Top Categories

Cellular Therapy

13

Leukemia

75

Lymphoma

74

Multiple Myeloma

66

Myelodysplastic Syndromes

25

Myeloproliferative Neoplasms

13

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Cellular Therapy

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Leukemia

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Lymphoma

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Multiple Myeloma

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Myelodysplastic Syndromes

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Loretta Nastoupil

What is the 2025 treatment landscape of follicular lymphoma?

Sagar Lonial

Facing 2026 with a mix of inspiration and trepidation

Phase 1 PROMISE Trial Updates

Adam Mead, MD, on interim phase 1 PROMise trial results in myelofibrosis

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.